ERK and the F-box protein betaTRCP target STAT1 for degradation

Surinder M Soond1, Paul A Townsend, Sean P Barry

  • 1Medical Molecular Biology Unit, Institute of Child Health, University College London, 30 Guilford Street, London WC1N 1EH, United Kingdom.

Insights

Signal transducer and activator of transcription 1 (STAT1) is degraded by the proteasome via ERK phosphorylation. This mechanism involves SCF(betaTRCP) and impacts STAT1’s tumor suppressor functions.

Area of Science:

  • Cellular biology
  • Molecular oncology
  • Signal transduction

Background:

  • Signal transducer and activator of transcription 1 (STAT1) is a transcription factor involved in various cellular processes, including apoptosis and tumor suppression.
  • STAT1 activity is tightly regulated, but the mechanisms controlling its stability are not fully understood.
  • Dysregulation of STAT1 is implicated in various pathologies, including cancer.

Purpose of the Study:

  • To elucidate the molecular mechanisms regulating STAT1 stability.
  • To investigate the role of post-translational modifications in STAT1 degradation.
  • To determine the implications of STAT1 dysregulation in tumor suppression.

Main Methods:

  • Western blotting to assess STAT1 protein levels.
  • Immunoprecipitation to study protein-protein interactions.
  • Site-directed mutagenesis to create nonphosphorylatable STAT1 mutants (STAT1(S727A)).
  • Pharmacological inhibition of ERK and silencing of betaTRCP expression.

Main Results:

  • Activated STAT1 is degraded via the proteasome through the F-box E3 ligase SCF(betaTRCP).
  • Mitogen-activated protein kinase kinase (MAPK)-extracellular signal-regulated kinase (ERK) phosphorylates STAT1 at serine 727, targeting it for degradation.
  • SCF(betaTRCP) directly binds to phosphorylated STAT1.
  • Inhibition of ERK or depletion of betaTRCP leads to STAT1 stabilization.

Conclusions:

  • ERK-mediated phosphorylation of STAT1 at serine 727 is a key step for its proteasomal degradation by SCF(betaTRCP).
  • This pathway represents a novel mechanism for STAT1 regulation.
  • Aberrant ERK activity may lead to inappropriate STAT1 degradation, potentially compromising its tumor suppressor functions.

Related Concept Videos

Regulated Protein Degradation02:58

Regulated Protein Degradation

It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Regulated Protein Degradation02:58

Regulated Protein Degradation

It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
The Unfolded Protein Response01:37

The Unfolded Protein Response

The ER is the hub of protein synthesis in a cell. It has robust systems to quality control protein folding and also for degradation of terminally misfolded proteins. Under normal conditions, a small proportion of misfolded proteins that cannot be salvaged need to be transported to the cytoplasm by the ER-associated degradation or ERAD pathways. However, if the ERAD cannot handle the misfolded proteins, the cell activates the unfolded protein response or UPR to adjust the protein folding...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...